Effects of Lowering Dialysate Calcium Concentration on Mineral and Bone Disorders in Chronic Hemodialysis Patients: Conversion from 3.0mEq/L to 2.75mEq/L

Shunsuke Yamada, Kenji Ueki, Masanori Tokumoto, Takaichi Suehiro, Hiroshi Kimura, Masatomo Taniguchi, Satoru Fujimi, Takanari Kitazono, Kazuhiko Tsuruya

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Selection of a lower dialysate calcium concentration (DCa) can reduce calcium burden and prevent vascular calcification in hemodialysis patients. However, decreased DCa can worsen mineral and bone disorders. This 1-year retrospective observational study evaluated 121 hemodialysis patients at Fukuoka Renal Clinic who underwent conversion of DCa from 3.0mEq/L to 2.75mEq/L. The primary outcomes were changes in serum levels of calcium, phosphate, and parathyroid hormone (PTH). The effects of baseline serum calcium and PTH levels on changes in biochemical parameters were also determined. One year after DCa conversion, mean serum calcium level decreased, while serum phosphate, alkaline phosphatase, and PTH concentrations increased. The rate of achievement of target PTH was higher in patients with lower serum PTH level at baseline, while patients with higher baseline serum PTH level tended to exceed the upper limit of the PTH target range. Patients with higher baseline serum calcium concentration showed a greater decrease in serum calcium level and a greater increase in serum PTH level at 1 year. Patients with a lower baseline serum PTH level can benefit from optimal PTH control following conversion of DCa from 3.0mEq/L to 2.75mEq/L. However, secondary hyperparathyroidism may be exacerbated in some patients with higher baseline serum calcium (Ca) and PTH levels. These results indicate that an individualized approach can maximize the benefits of Ca unloading after conversion to lower DCa.

Original languageEnglish (US)
Pages (from-to)31-39
Number of pages9
JournalTherapeutic Apheresis and Dialysis
Volume20
Issue number1
DOIs
StatePublished - Feb 1 2016

Fingerprint

Dialysis Solutions
Minerals
Renal Dialysis
Parathyroid Hormone
Calcium
Bone and Bones
Serum
Vascular Calcification
Secondary Hyperparathyroidism
Observational Studies
Alkaline Phosphatase
Retrospective Studies
Phosphates

Keywords

  • Chronic kidney disease-mineral and bone disorder
  • Dialysate calcium concentration
  • Hemodialysis
  • Parathyroid hormone
  • Secondary hyperparathyroidism

ASJC Scopus subject areas

  • Hematology
  • Nephrology

Cite this

Effects of Lowering Dialysate Calcium Concentration on Mineral and Bone Disorders in Chronic Hemodialysis Patients : Conversion from 3.0mEq/L to 2.75mEq/L. / Yamada, Shunsuke; Ueki, Kenji; Tokumoto, Masanori; Suehiro, Takaichi; Kimura, Hiroshi; Taniguchi, Masatomo; Fujimi, Satoru; Kitazono, Takanari; Tsuruya, Kazuhiko.

In: Therapeutic Apheresis and Dialysis, Vol. 20, No. 1, 01.02.2016, p. 31-39.

Research output: Contribution to journalArticle

Yamada, Shunsuke ; Ueki, Kenji ; Tokumoto, Masanori ; Suehiro, Takaichi ; Kimura, Hiroshi ; Taniguchi, Masatomo ; Fujimi, Satoru ; Kitazono, Takanari ; Tsuruya, Kazuhiko. / Effects of Lowering Dialysate Calcium Concentration on Mineral and Bone Disorders in Chronic Hemodialysis Patients : Conversion from 3.0mEq/L to 2.75mEq/L. In: Therapeutic Apheresis and Dialysis. 2016 ; Vol. 20, No. 1. pp. 31-39.
@article{1f5311e19af64dc3a51f91bad189a301,
title = "Effects of Lowering Dialysate Calcium Concentration on Mineral and Bone Disorders in Chronic Hemodialysis Patients: Conversion from 3.0mEq/L to 2.75mEq/L",
abstract = "Selection of a lower dialysate calcium concentration (DCa) can reduce calcium burden and prevent vascular calcification in hemodialysis patients. However, decreased DCa can worsen mineral and bone disorders. This 1-year retrospective observational study evaluated 121 hemodialysis patients at Fukuoka Renal Clinic who underwent conversion of DCa from 3.0mEq/L to 2.75mEq/L. The primary outcomes were changes in serum levels of calcium, phosphate, and parathyroid hormone (PTH). The effects of baseline serum calcium and PTH levels on changes in biochemical parameters were also determined. One year after DCa conversion, mean serum calcium level decreased, while serum phosphate, alkaline phosphatase, and PTH concentrations increased. The rate of achievement of target PTH was higher in patients with lower serum PTH level at baseline, while patients with higher baseline serum PTH level tended to exceed the upper limit of the PTH target range. Patients with higher baseline serum calcium concentration showed a greater decrease in serum calcium level and a greater increase in serum PTH level at 1 year. Patients with a lower baseline serum PTH level can benefit from optimal PTH control following conversion of DCa from 3.0mEq/L to 2.75mEq/L. However, secondary hyperparathyroidism may be exacerbated in some patients with higher baseline serum calcium (Ca) and PTH levels. These results indicate that an individualized approach can maximize the benefits of Ca unloading after conversion to lower DCa.",
keywords = "Chronic kidney disease-mineral and bone disorder, Dialysate calcium concentration, Hemodialysis, Parathyroid hormone, Secondary hyperparathyroidism",
author = "Shunsuke Yamada and Kenji Ueki and Masanori Tokumoto and Takaichi Suehiro and Hiroshi Kimura and Masatomo Taniguchi and Satoru Fujimi and Takanari Kitazono and Kazuhiko Tsuruya",
year = "2016",
month = "2",
day = "1",
doi = "10.1111/1744-9987.12329",
language = "English (US)",
volume = "20",
pages = "31--39",
journal = "Therapeutic Apheresis and Dialysis",
issn = "1744-9979",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Effects of Lowering Dialysate Calcium Concentration on Mineral and Bone Disorders in Chronic Hemodialysis Patients

T2 - Conversion from 3.0mEq/L to 2.75mEq/L

AU - Yamada, Shunsuke

AU - Ueki, Kenji

AU - Tokumoto, Masanori

AU - Suehiro, Takaichi

AU - Kimura, Hiroshi

AU - Taniguchi, Masatomo

AU - Fujimi, Satoru

AU - Kitazono, Takanari

AU - Tsuruya, Kazuhiko

PY - 2016/2/1

Y1 - 2016/2/1

N2 - Selection of a lower dialysate calcium concentration (DCa) can reduce calcium burden and prevent vascular calcification in hemodialysis patients. However, decreased DCa can worsen mineral and bone disorders. This 1-year retrospective observational study evaluated 121 hemodialysis patients at Fukuoka Renal Clinic who underwent conversion of DCa from 3.0mEq/L to 2.75mEq/L. The primary outcomes were changes in serum levels of calcium, phosphate, and parathyroid hormone (PTH). The effects of baseline serum calcium and PTH levels on changes in biochemical parameters were also determined. One year after DCa conversion, mean serum calcium level decreased, while serum phosphate, alkaline phosphatase, and PTH concentrations increased. The rate of achievement of target PTH was higher in patients with lower serum PTH level at baseline, while patients with higher baseline serum PTH level tended to exceed the upper limit of the PTH target range. Patients with higher baseline serum calcium concentration showed a greater decrease in serum calcium level and a greater increase in serum PTH level at 1 year. Patients with a lower baseline serum PTH level can benefit from optimal PTH control following conversion of DCa from 3.0mEq/L to 2.75mEq/L. However, secondary hyperparathyroidism may be exacerbated in some patients with higher baseline serum calcium (Ca) and PTH levels. These results indicate that an individualized approach can maximize the benefits of Ca unloading after conversion to lower DCa.

AB - Selection of a lower dialysate calcium concentration (DCa) can reduce calcium burden and prevent vascular calcification in hemodialysis patients. However, decreased DCa can worsen mineral and bone disorders. This 1-year retrospective observational study evaluated 121 hemodialysis patients at Fukuoka Renal Clinic who underwent conversion of DCa from 3.0mEq/L to 2.75mEq/L. The primary outcomes were changes in serum levels of calcium, phosphate, and parathyroid hormone (PTH). The effects of baseline serum calcium and PTH levels on changes in biochemical parameters were also determined. One year after DCa conversion, mean serum calcium level decreased, while serum phosphate, alkaline phosphatase, and PTH concentrations increased. The rate of achievement of target PTH was higher in patients with lower serum PTH level at baseline, while patients with higher baseline serum PTH level tended to exceed the upper limit of the PTH target range. Patients with higher baseline serum calcium concentration showed a greater decrease in serum calcium level and a greater increase in serum PTH level at 1 year. Patients with a lower baseline serum PTH level can benefit from optimal PTH control following conversion of DCa from 3.0mEq/L to 2.75mEq/L. However, secondary hyperparathyroidism may be exacerbated in some patients with higher baseline serum calcium (Ca) and PTH levels. These results indicate that an individualized approach can maximize the benefits of Ca unloading after conversion to lower DCa.

KW - Chronic kidney disease-mineral and bone disorder

KW - Dialysate calcium concentration

KW - Hemodialysis

KW - Parathyroid hormone

KW - Secondary hyperparathyroidism

UR - http://www.scopus.com/inward/record.url?scp=84958121718&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958121718&partnerID=8YFLogxK

U2 - 10.1111/1744-9987.12329

DO - 10.1111/1744-9987.12329

M3 - Article

C2 - 26482334

AN - SCOPUS:84958121718

VL - 20

SP - 31

EP - 39

JO - Therapeutic Apheresis and Dialysis

JF - Therapeutic Apheresis and Dialysis

SN - 1744-9979

IS - 1

ER -